US Stock MarketDetailed Quotes

ZVRA Zevra Therapeutics

Watchlist
  • 6.300
  • 0.0000.00%
Trading Aug 1 16:00 ET
263.68MMarket Cap-4772P/E (TTM)

Zevra Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Zevra Therapeutics Earnings Date

Currency: USD

Period

Q2 FY2024 Estimates

Aug 13, 2024

Revenue(YoY)

4.41M

-47.97%
EPS(YoY)

-0.44

-192.33%
Analyst Rating

Strong Buy

Aug 1, 2024

Zevra Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 5.447M--
Aug 13, 20242024/Q2-- / 4.407M--
May 8, 20242024/Q13.425M / 3.759M--
Mar 28, 20242023/Q413.217M / 11.738M--
Nov 7, 20232023/Q32.895M / 3.379M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 5.447M--
Aug 13, 20242024/Q2-- / 4.407M--
May 8, 20242024/Q13.425M / 3.759M--
Mar 28, 20242023/Q413.217M / 11.738M--
Nov 7, 20232023/Q32.895M / 3.379M--

Unlock Free Earnings Estimates

Zevra Therapeutics Earnings Reports

  • 10-Q: Quarterly report

    May 10 04:38

  • Zevra Therapeutics | 10-K: Annual report

    Apr 2 05:33

  • Zevra Therapeutics: Q3 2023 Earnings Report

    Nov 8, 2023 06:23

  • Zevra Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 15, 2023 04:34

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 1, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg